IPO registrations (S-1, F-1) · Registrants
Adaptive Biotechnologies Corp
- SEC CIK
- 1478320 · filings on EDGAR ↗
- Former names
- Adaptive TCR Corp (2009–2011)
- Registration
- Form S-1, first filed 2019-05-30, last 2020-01-22; 2 initial registrations, 4 amendments
- Outcome
- Final prospectus filed 2019-06-27; declared effective 2019-06-26
- Industry (SIC)
- Biological Products, (No Diagnostic Substances) 2836
- Incorporated in
- WA
- Business address
- 1165 EASTLAKE AVE E, Seattle, WA 98109
- EIN
- 27-0907024
- Ticker
- ADPT (Nasdaq)
- EDGAR entity type
- operating
- Insiders and CEO pay
- Adaptive Biotechnologies Corp on the corporate pages
Offering terms
- Proposed price range
- $18.00–$19.00 per share (S-1/A filed 2019-06-26)
- Final price
- $20.00 per share, above the range (424B4 filed 2019-06-27, an initial public offering)
- Shares sold
- 15,000,000
- Gross proceeds
- $300,000,000 before underwriting discounts and any over-allotment option
- Listing
- Nasdaq under the symbol ADPT
- Lead underwriters
- Goldman Sachs; J.P. Morgan; BofA Securities
- Syndicate
- Cowen; Guggenheim Securities; William Blair; BTIG
Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.
On this site
- Business registration: ADAPTIVE BIOTECHNOLOGIES CORPORATION EXACT (EIN (EXACT, as the state registration reports it))
- Business registration: ADAPTIVE BIOTECHNOLOGIES CORPORATION EXACT (EIN (EXACT, as the state registration reports it))
- Business registration: Adaptive Biotechnologies Corporation Fuzzy (name and state)
- Business registration: Adaptive Biotechnologies Corporation Fuzzy (name and state)
- Business registration: Adaptive Biotechnologies Corporation Fuzzy (name and state)
- Business registration: Adaptive Biotechnologies Corporation Fuzzy (name and state)
- Business registration: ADAPTIVE BIOTECHNOLOGIES Corporation Fuzzy (name and state)
- Business registration: ADAPTIVE BIOTECHNOLOGIES CORPORATION Fuzzy (name and state)
- Business registration: ADAPTIVE BIOTECHNOLOGIES CORPORATION Fuzzy (name and state)
- Business registration: ADAPTIVE BIOTECHNOLOGIES CORPORATION Fuzzy (name and state)
- Business registration: ADAPTIVE BIOTECHNOLOGIES CORPORATION Fuzzy (name and state)
- Business registration: ADAPTIVE BIOTECHNOLOGIES CORPORATION Fuzzy (name and state)
- Form 5500 plan sponsor: ADAPTIVE BIOTECHNOLOGIES CORPORATION EXACT (EIN (EXACT))
- Federal award recipient: ADAPTIVE BIOTECHNOLOGIES CORPORATION Fuzzy (name and state)
- Form D issuer: Adaptive Biotechnologies Corp EXACT (CIK (EXACT))
- Lobbying client: ADAPTIVE BIOTECHNOLOGIES Fuzzy (name and state)
- Lobbying client: ADAPTIVE BIOTECHNOLOGIES Fuzzy (name and state)
- Lobbying client: ADAPTIVE BIOTECHNOLOGIES Fuzzy (name and state)
- Lobbying client: ADAPTIVE BIOTECHNOLOGIES CORP Fuzzy (name and state)
- Lobbying registrant: ADAPTIVE BIOTECHNOLOGIES Fuzzy (name and state)
- SEC filer: Adaptive Biotechnologies Corp EXACT (CIK (EXACT))
- Person page: Ole Andreas Halvorsen Fuzzy (officer, director or 10% owner on the company's Forms 3, 4 and 5 (TenPercentOwner))
- Person page: Peter M Neupert Fuzzy (officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director))
Filings 10
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 2019-05-30 | S-1 | S-1 (registration) | Adaptive Biotechnologies Corp | 0001193125-19-161447 ↗ |
| 2019-06-17 | S-1/A | S-1/A (amendment) | Adaptive Biotechnologies Corp | 0001193125-19-174174 ↗ |
| 2019-06-19 | S-1/A | S-1/A (amendment) | Adaptive Biotechnologies Corp | 0001193125-19-176598 ↗ |
| 2019-06-26 | S-1/A | S-1/A (amendment) | Adaptive Biotechnologies Corp | 0001193125-19-182012 ↗ |
| 2019-06-26 | EFFECT | EFFECT (declared effective) | Adaptive Biotechnologies Corp | 9999999995-19-001450 ↗ |
| 2019-06-27 | 424B4 | 424B4 (final prospectus) | Adaptive Biotechnologies Corp | 0001193125-19-184483 ↗ |
| 2020-01-21 | S-1 | S-1 (registration) | Adaptive Biotechnologies Corp | 0001193125-20-011067 ↗ |
| 2020-01-22 | S-1/A | S-1/A (amendment) | Adaptive Biotechnologies Corp | 0001193125-20-012051 ↗ |
| 2020-01-23 | EFFECT | EFFECT (declared effective) | Adaptive Biotechnologies Corp | 9999999995-20-000152 ↗ |
| 2020-01-24 | 424B4 | 424B4 (final prospectus) | Adaptive Biotechnologies Corp | 0001193125-20-014285 ↗ |
Prospectus pages read 2
| Filed | Form | Read as | Range | Price | Shares | Proceeds | Listing | Underwriters | What was found | Document |
|---|---|---|---|---|---|---|---|---|---|---|
| 2019-06-26 | S-1/A | registration statement | $18.00–$19.00 | 15,000,000 | - | Nasdaq ADPT | 7 | primary document; range, shares headline, cover names 7 | document ↗ | |
| 2019-06-27 | 424B4 | final prospectus | $20.00 | 15,000,000 | $300,000,000 | Nasdaq ADPT | 7 | primary document; price sentence, shares headline, proceeds table, cover names 7 | document ↗ |
Officers, directors and large holders Forms 3, 4 and 5
| Insider | Role | Title | Filings | Years | On this site |
|---|---|---|---|---|---|
| BALDO LANCE | Officer | Chief Medical Officer | 17 | 2019–2022 | |
| BENZENO SHARON | Officer | Chief Business Development Off; Chief Commercial Ofc Imm Med; Sr VP, Drug Discovery; SVP, Drug Discovery | 37 | 2019–2026 | |
| Cohen Chad M | Officer | Chief Financial Officer | 39 | 2019–2021 | |
| Conroy Kevin T | Director | 5 | 2019–2023 | ||
| DOBMEIER ERIC | Director | 13 | 2019–2021 | ||
| GOEL DAVID E. | Director; DirectorOther; Director,TenPercentOwner; Director,TenPercentOwnerOther | 7 | 2019–2021 | ||
| GRIFFIN MICHELLE RENEE | Director | 24 | 2019–2026 | ||
| HALVORSEN OLE ANDREAS | TenPercentOwner | 9 | 2019–2020 | person page Fuzzy | |
| HERSHBERG ROBERT | Director | 24 | 2019–2026 | ||
| HILL NANCY LOUISE | Officer | EVP, Operations & Program Mana; Senior VP, Operations; Sr Vice President, Operations; SVP, Operations | 11 | 2019–2021 | |
| LO FRANCIS | Officer | Chief People Officer | 35 | 2019–2026 | |
| Matrix Capital Management Company, LP | DirectorOther; Director,TenPercentOwnerOther | 5 | 2019–2021 | ||
| NEUPERT PETER M | Director | 12 | 2019–2026 | person page Fuzzy | |
| NOLAN SEAN PATRICK | Officer | Chief Technology Officer | 1 | 2019 | |
| Ott David C. | TenPercentOwner | 9 | 2019–2020 | ||
| Pellini Michael J | Director | 11 | 2019–2025 | ||
| PISKEL KYLE | Officer | Chief Financial Officer; Corporate Controller; Principal Accounting Officer | 22 | 2019–2026 | |
| ROBINS CHAD M | Director,Officer | CEO and Chairman | 44 | 2019–2026 | |
| ROBINS HARLAN S | Officer | Chief Scientific Officer | 51 | 2019–2026 | |
| RUBINSTEIN JULIE | Officer | President; President and COO | 58 | 2019–2026 | |
| SANG CHARLES | Officer | Sr VP, Clinical Diagnostics; SVP, Clinical Diagnostics; SVP, External Affairs | 5 | 2019–2020 | |
| Shabet Rose Sharon | TenPercentOwner | 9 | 2019–2020 | ||
| VGE III Portfolio Ltd. | TenPercentOwner | 1 | 2019 | ||
| Viking Global Equities II LP | TenPercentOwner | 4 | 2019–2020 | ||
| Viking Global Equities LP | TenPercentOwner | 1 | 2019 | ||
| Viking Global Equities Master Ltd. | TenPercentOwner | 5 | 2019–2020 | ||
| VIKING GLOBAL INVESTORS LP | TenPercentOwner | 5 | 2019–2020 | ||
| Viking Global Opportunities GP LLC | TenPercentOwner | 4 | 2019–2020 | ||
| Viking Global Opportunities Illiquid Investments Sub-Master LP | TenPercentOwner | 4 | 2019–2020 | ||
| Viking Global Opportunities Portfolio GP LLC | TenPercentOwner | 4 | 2019–2020 | ||
| VIKING GLOBAL PERFORMANCE LLC | TenPercentOwner | 5 | 2019–2020 | ||
| Viking Long Fund GP LLC | TenPercentOwner | 5 | 2019–2020 | ||
| Viking Long Fund Master Ltd. | TenPercentOwner | 5 | 2019–2020 | ||
| ZOLTNERS ANDRIS A | Director | 4 | 2019–2020 | ||
| Taylor Stacy L | Officer | SVP and General Counsel | 28 | 2020–2024 | |
| Palaniappan Jyoti | Officer | SVP, Diagnostics, immunoSEQ Dx; SVP, Diagnostics, T-Detect | 8 | 2020–2021 | |
| ADAMS R MARK | Officer | Chief Operating Officer; Chief Technical Officer; EVP & Chief Operating Officer | 16 | 2020–2023 | |
| BOBULSKY SUSAN | Officer | Chief Commercial Officer, MRD; SVP, Diagnostics, clonoSEQ | 19 | 2020–2026 | |
| Trigg Leslie | Director | 4 | 2021–2023 | ||
| OWEN KATEY EINTERZ | Director | 9 | 2021–2026 | ||
| THORSEN HENNING | Officer | SVP, Commercial Operations | 2 | 2021 | |
| SOOD NITIN | Officer | Chief Commercial Officer; Chief Commercial Officer, MRD | 7 | 2021–2023 | |
| PETERSON TYCHO | Officer | Chief Financial Officer | 7 | 2022–2024 |
Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.
Private offerings before or after (Form D)
| First filed | Issuer | Industry | Offering | Sold | Investors | Filings |
|---|---|---|---|---|---|---|
| 2015-05-11 | Adaptive Biotechnologies Corp | Biotechnology | $195,099,954 | $195,099,954 | 16 | 1 |
| 2015-01-22 | Adaptive Biotechnologies Corp | Biotechnology | $93,750,000 | $93,750,000 | 4 | 1 |
| 2015-01-21 | Adaptive Biotechnologies Corp | Biotechnology | $95,716,444 | $95,716,444 | 61 | 1 |
| 2014-04-15 | Adaptive Biotechnologies Corp | Biotechnology | $106,999,480 | $106,999,480 | 6 | 2 |
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.
Also on this site Fuzzy
| Record | Name as filed | Where | Dataset | Matched by |
|---|---|---|---|---|
| Business registration | ADAPTIVE BIOTECHNOLOGIES CORPORATION | WA | State business registries | EIN (EXACT, as the state registration reports it) |
| Business registration | ADAPTIVE BIOTECHNOLOGIES CORPORATION | WA | State business registries | EIN (EXACT, as the state registration reports it) |
| Plan sponsor | ADAPTIVE BIOTECHNOLOGIES CORPORATION | WA | Form 5500 (employee benefit plans) | name and state |
| Federal award recipient | ADAPTIVE BIOTECHNOLOGIES CORPORATION | WA | Federal spending (USAspending) | name and state |
| Form D issuer | Adaptive Biotechnologies Corp | WA | Form D private offerings | CIK (EXACT) |
| Lobbying client | ADAPTIVE BIOTECHNOLOGIES | WA | Federal lobbying (LDA) | name and state |
| Lobbying client | ADAPTIVE BIOTECHNOLOGIES | WA | Federal lobbying (LDA) | name and state |
| Lobbying client | ADAPTIVE BIOTECHNOLOGIES | WA | Federal lobbying (LDA) | name and state |
| Lobbying client | ADAPTIVE BIOTECHNOLOGIES CORP | WA | Federal lobbying (LDA) | name and state |
| Lobbying registrant | ADAPTIVE BIOTECHNOLOGIES | WA | Federal lobbying (LDA) | name and state |
| Paying company | Adaptive Biotechnologies Corporation | WA | Open Payments (drug and device company payments) | name and state |
| Patent assignee | Adaptive Biotechnologies Corporation | WA | Patents (USPTO) | name and state |
| SEC filer | Adaptive Biotechnologies Corp | SEC filers (EDGAR) | CIK (EXACT) | |
| Trademark owner | Adaptive Biotechnologies Corporation | WA | Trademarks (USPTO) | name and state |
| Business registration | Adaptive Biotechnologies Corporation | State business registries | name and state | |
| Business registration | Adaptive Biotechnologies Corporation | State business registries | name and state | |
| Business registration | Adaptive Biotechnologies Corporation | State business registries | name and state | |
| Business registration | Adaptive Biotechnologies Corporation | State business registries | name and state | |
| Business registration | ADAPTIVE BIOTECHNOLOGIES Corporation | State business registries | name and state | |
| Business registration | ADAPTIVE BIOTECHNOLOGIES CORPORATION | State business registries | name and state | |
| Business registration | ADAPTIVE BIOTECHNOLOGIES CORPORATION | State business registries | name and state | |
| Business registration | ADAPTIVE BIOTECHNOLOGIES CORPORATION | State business registries | name and state | |
| Business registration | ADAPTIVE BIOTECHNOLOGIES CORPORATION | State business registries | name and state | |
| Business registration | ADAPTIVE BIOTECHNOLOGIES CORPORATION | State business registries | name and state | |
| Form 5500 plan sponsor | ADAPTIVE BIOTECHNOLOGIES CORPORATION | EIN (EXACT) | ||
| Person page | Ole Andreas Halvorsen | People (Form 990 officers, directors and employees) | officer, director or 10% owner on the company's Forms 3, 4 and 5 (TenPercentOwner) | |
| Person page | Peter M Neupert | People (Form 990 officers, directors and employees) | officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director) |
Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.
Others with the same interests
SIC industry Biological Products, (No Diagnostic Substances), WA first:
- CORIXA CORP WA
- Seagen Inc. WA
- ZYMOGENETICS INC WA
- NS Wind Down Co., Inc. WA
- Juno Therapeutics, Inc. WA
- LeonaBio, Inc. WA
- Sana Biotechnology, Inc. WA
- Icosavax, Inc. WA
- Intrinsic Medicine, Inc. WA
- Aurion Biotech, Inc. WA
In other datasets, the same topic (Health) in WA:
- Nonprofit: ACUPUNCTURE RELIEF PROJECT (Nonprofits (IRS Form 990))
Interests: Biological Products, (No Diagnostic Substances) · Health